(Q64071499)
Statements
MEK1/2 inhibitor withdrawal reverses acquired resistance driven by BRAFV600E amplification whereas KRASG13D amplification promotes EMT-chemoresistance (English)
Matthew J Sale
Kathryn Balmanno
Jayeta Saxena
Katarzyna Wojdyla
Rebecca E McIntyre
Rebecca Gilley
Anna Woroniuk
Karen D Howarth
Gareth Hughes
Jonathan R Dry
Pilar Caro
David Oxley
Susan Ashton
David J Adams